Pentoxifylline and α-Tocopherol Study for RILI in Stage III NSCLC Patients
A clinical trial is investigating the efficacy of Pentoxifylline and α-Tocopherol in preventing radiation-induced lung injury in stage III NSCLC patients.
Indication
Clinical and regulatory intelligence for Non-Small Cell Lung Cancer with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.